Clinical Report: The Role of Adjuvant Radiotherapy in Managing WHO Grade II Meningiomas

Overview

This study investigates the impact of adjuvant radiotherapy on progression-free survival (PFS) and cause-specific survival (CSS) in patients with WHO grade II meningiomas. Results indicate that adjuvant radiotherapy is associated with decreased PFS and CSS.

Background

WHO grade II meningiomas are known for their aggressive behavior and high recurrence rates. The role of adjuvant radiotherapy post-surgery remains controversial, with varying recommendations from clinical guidelines.

Data Highlights

Key Findings

• Adjuvant radiotherapy significantly reduced PFS after both GTR and STR.
• CSS was also less following radiotherapy after GTR.
• Stereotactic fractionated conformal radiotherapy and radiosurgery were independent predictors of recurrence and death.
• Competing risk models indicated increased hazards of recurrence and mortality across all irradiation modalities.

Clinical Implications

Clinicians should consider the results when discussing treatment options with patients.

Conclusion

Adjuvant radiotherapy is associated with decreased PFS and CSS in WHO grade II meningiomas.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. NCCN Central Nervous System Cancers Guidelines
6. Joint EANM/EANO/RANO/SNMMI practice guideline
7. Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539 - PMC
8. Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma - PubMed
9. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042) - PubMed
10. EORTC
11. NRG-BN003 - NRG Oncology
12. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis - PMC
13. Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study - PMC
14. NCOG-54. Timing of adjuvant radiotherapy impacts overall survival for atypical intracranial meningiomas: a National Cancer Database (NCDB) analysis | Neuro-Oncology | Oxford Academic
15. Toxicities Associated with Adjuvant Radiation Therapy in Atypical Meningioma - PubMed